Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening.

scientific article published in March 2009

Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1747-0285.2009.00780.X
P698PubMed publication ID19207463
P5875ResearchGate publication ID23997980

P50authorAlberto Del RioQ37604916
Giulio RastelliQ42396668
Gianluca DegliespostiQ96088288
P2093author name stringMiriam Sgobba
P433issue3
P921main subjectautomationQ184199
P304page(s)283-286
P577publication date2009-03-01
P1433published inChemical Biology and Drug DesignQ15749458
P1476titleBinding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening.
P478volume73

Reverse relations

cites work (P2860)
Q43122434A computational workflow for the design of irreversible inhibitors of protein kinases.
Q54589320Assessing protein kinase selectivity with molecular dynamics and mm-pbsa binding free energy calculations.
Q48113134Assessing protein-ligand binding modes with computational tools: the case of PDE4B.
Q33749271BEAR, a novel virtual screening methodology for drug discovery.
Q58719254Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview
Q37848281Challenges and advances in computational docking: 2009 in review
Q46251798Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents
Q96640272DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1
Q42168065Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids.
Q30432286Effects of organic solvents and substrate binding on trypsin in acetonitrile and hexane media
Q51280448FEW: a workflow tool for free energy calculations of ligand binding.
Q35214824Hierarchical virtual screening approaches in small molecule drug discovery
Q42274678High throughput molecular dynamics for drug discovery.
Q91928592In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)
Q93200291Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2
Q35621988Knowledge-guided docking: accurate prospective prediction of bound configurations of novel ligands using Surflex-Dock
Q58557345Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer's Disease: A Computational Study
Q93126855Molecular Docking: Shifting Paradigms in Drug Discovery
Q30395513Molecular mechanism of carbon nanotube to activate Subtilisin Carlsberg in polar and non-polar organic media
Q40551036Prediction of the substrate for nonribosomal peptide synthetase (NRPS) adenylation domains by virtual screening
Q30629561Probing immobilization mechanism of alpha-chymotrypsin onto carbon nanotube in organic media by molecular dynamics simulation
Q93202753Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein-ligand recognition process
Q92243083Refinement and Rescoring of Virtual Screening Results
Q63940611Relative Binding Energies Predict Crystallographic Binding Modes of Ethionamide Booster Lead Compounds
Q50900960Selective inhibitors of human mPGES-1 from structure-based computational screening.
Q90573312Standardization of virtual-screening and post-processing protocols relevant to in-silico drug discovery
Q92153139Tetrahydroquinoline-Isoxazole/Isoxazoline Hybrid Compounds as Potential Cholinesterases Inhibitors: Synthesis, Enzyme Inhibition Assays, and Molecular Modeling Studies
Q38242056The cloud and other new computational methods to improve molecular modelling.
Q28543708The interaction of RNA helicase DDX3 with HIV-1 Rev-CRM1-RanGTP complex during the HIV replication cycle
Q41902016Towards automated binding affinity prediction using an iterative linear interaction energy approach
Q52654588Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
Q30366496Virtual screening: an in silico tool for interlacing the chemical universe with the proteome.
Q33437882WISDOM-II: screening against multiple targets implicated in malaria using computational grid infrastructures

Search more.